Aina Muceniece (23.03.1924.-14.02.2010.)
The inventor of Rigvir
Honourable Member of Latvian Academy of Sciences (1992)
Emeritus Scientist for the problems of immunology, oncology, and virology
Cross of Recognition for special services for the benefit of Latvia (2005)
“...To treat cancer with a virus is a fantastic idea which occurred in the beginning of the last century. Before the World War I, cancer was already treated with the rabies virus vaccine and other viruses. I managed to find a virus which is not dangerous for a man. This virus can be found in intestines of healthy children. Unlike the chemotherapy and the radiation therapy, this medicine does not leave such serious consequences in patient's organs. The world began to speak in the beginning of the '90s about what I have discovered in the '70s. While reading conclusions drawn by Japanese and American scientists, I had a feeling that I am going through my own book...”
Professor, Dr. habil. chem. Ivars Kalvins,
European Academy of Sciencies and Arts (Salzburg),
Corresponding Member, Latvian Academy of Sciences,
Director of Latvian Institute of Organic Synthesis: www.osi.lv,
author of Mildronate and Leakadine,
author of 550 publications, including patents,
Certificate and Golden Medal of World Intellectual Property Organisation (WIPO) for
long-term and highly productive work as an inventor.
“…Cancer virotherapy is one of the most promising modern cancer therapy methods. Therefore, the leading countries in the development of pharmaceutical products have largely involved in virological researches with the aim of finding the most effective and safest viruses with the ability to selectively destroy malignant cells. Nobody doubts any more that viruses are able to do it. Just like nobody doubts any more that Latvia through Rigvir has become the leader and, at the same time, the pioneer in virotherapy. The only question is – how much time will it take until some other viral anticancer medicines will join Rigvir. Clearer and stronger with every day, virotherapy is claimed around the world as one of the firm primary therapy types, that can be more effective, safer, and patient-caring than the cancer treatment methods known until now…”
Ingrida Circene, MD
The Minister of Health of the Republic of Latvia
"...Today we can be proud that Rigvir is not only our success story, but at the same
time it is a real help and hope for cancer patients not only in Latvia, but all around
"...In the sixties of the last century, Latvian scientists proved the ability of viruses to fight malignant tumours by adapting a specific virus that was named Rigvir (Riga virus) to melanoma tissues. In the next decades, scientists worked actively to prove effectiveness of the virus in various preclinical and clinical trials both in Latvia and in the rest of the world. In 2004, Rigvir was registered as a cancer-treating medicine and in 2005 the Latvian Academy of Sciences acknowledged Rigvir as one of the greatest inventions in Latvia..."
Copyright © 2014 Latvian Virotherapy Center, Ltd - All rights reserved.